Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Russell 2000 Ishares ETF (IWM)

Russell 2000 Ishares ETF (IWM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family BlackRock iShares
  • Assets Under Management 81,252,320,000
  • Shares Outstanding, K 335,350
  • 60-Month Beta 1.15
  • Price/Earnings ttm 10.96
  • Annual Dividend & Yield 2.57 (1.06%)
  • Most Recent Dividend 0.752 on 09/25/24
  • Management Fee 0.19%
  • Sectors:

    ETFs - Small Cap

Options Overview Details

View History
  • Implied Volatility 22.02% ( +0.19%)
  • Historical Volatility 23.19%
  • IV Percentile 64%
  • IV Rank 26.32%
  • IV High 37.84% on 08/05/24
  • IV Low 16.37% on 05/24/24
  • Put/Call Vol Ratio 0.55
  • Today's Volume 398,168
  • Volume Avg (30-Day) 1,449,384
  • Put/Call OI Ratio 2.07
  • Today's Open Interest 12,005,681
  • Open Int (30-Day) 11,598,764

Price Performance

See More
Period Period Low Period High Performance
1-Month
217.63 +11.06%
on 10/31/24
244.98 -1.34%
on 11/25/24
+22.81 (+10.42%)
since 10/25/24
3-Month
204.21 +18.36%
on 09/11/24
244.98 -1.34%
on 11/25/24
+22.96 (+10.50%)
since 08/27/24
52-Week
177.20 +36.40%
on 11/28/23
244.98 -1.34%
on 11/25/24
+62.97 (+35.23%)
since 11/27/23

Most Recent Stories

More News
CervoMed Stock Surges On FDA Orphan Drug Nod For FTD Treatment: Retail Optimism Rekindled

The Orphan Drug status provides CervoMed with several key benefits, including tax credits for clinical trial costs, regulatory assistance, and seven years of post-approval market exclusivity.

IWC : 137.43 (+0.42%)
VXF : 204.54 (-0.09%)
CRVO : 9.27 (+16.17%)
VTI : 298.49 (-0.19%)
IWM : 241.22 (+0.25%)
Hanesbrands Stock Rises On UBS Upgrade: Retail’s Neutral

The brokerage expects a compound annual growth rate (CAGR) of about 24% in EPS after the current fiscal 2024.

IJR : 126.57 (+0.33%)
IWO : 312.71 (-0.01%)
HBI : 8.76 (-0.90%)
IWM : 241.22 (+0.25%)
S&P 500 Set to Touch 6,500 by 2025: ETFs to Watch for Big Wins

Recently, Goldman Sachs predicted that the S&P 500 index will climb to 6,500 by late 2025, driven by sustained U.S. economic growth and robust corporate earnings, according to Yahoo Finance. This marks...

MAGS : 50.83 (-1.21%)
IVV : 602.38 (-0.23%)
VUG : 405.08 (-0.74%)
IVW : 99.89 (-0.76%)
VB : 259.78 (-0.05%)
QQQ : 503.97 (-1.05%)
IJR : 126.57 (+0.33%)
MGK : 336.53 (-0.85%)
VOO : 550.93 (-0.25%)
IWF : 394.74 (-0.81%)
QQQM : 207.50 (-1.02%)
SPY : 599.21 (-0.24%)
Anavex Stock Jumps Pre-Market After Submitting Oral Alzheimer's Drug To European Regulators For Approval: Retail Over The Moon

D. Boral Capital believes Anavex’s Alzheimer’s treatment is superior to Cassava Sciences' approach.

AVXL : 9.02 (-0.11%)
VTI : 298.49 (-0.19%)
IWM : 241.22 (+0.25%)
SAVA : 4.06 (+6.01%)
Trump Tariffs on Canada and Mexico Put These ETFs in Focus

On Nov. 25, 2024, President-elect Donald Trump announced plans to impose a 25% tariff on imports from Canada and Mexico, citing the need to curb drug trafficking, particularly fentanyl, and illegal migration....

FXC : 69.62 (+0.15%)
EWC : 42.85 (+0.59%)
EWW : 48.77 (-0.37%)
CORN : 17.81 (+0.24%)
CARZ : 58.00 (-0.15%)
IWM : 241.22 (+0.25%)
Abercrombie & Fitch Stock Rises Ahead Of Q3 Earnings: Retail’s Bullish

Wall Street analysts expect Abercrombie to announce earnings of $2.39 per share on revenues of $1.19 billion.

ANF : 149.98 (+2.29%)
VTI : 298.49 (-0.19%)
XRT : 83.20 (+0.58%)
VB : 259.78 (-0.05%)
IWM : 241.22 (+0.25%)
Biohaven’s SMA Trial Miss Bolsters Scholar Rock Stock: Analysts Give Verdicts, Retail Watches Closely

Last month, Scholar Rock achieved the primary endpoint in the company's own Phase 3 trial of apitegromab in SMA patients.

BHVN : 46.77 (-1.08%)
VTI : 298.49 (-0.19%)
SRRK : 37.36 (+0.81%)
IWM : 241.22 (+0.25%)
XBI : 99.25 (+0.40%)
Summit Materials Stock Slips On $11.5B Sale To Rival Quickrete: Retail’s Cautious

The transaction price represents a 36% premium to Summit's 90-day volume weighted average price

VXF : 204.54 (-0.09%)
SUM : 50.86 (+0.02%)
VTI : 298.49 (-0.19%)
IWM : 241.22 (+0.25%)
Cassava Sciences Stock Craters After Alzheimer’s Disease Trial Flops: Retail’s Devastated

The CEO noted that the findings also impact the company’s second Phase 3 trial, ReFocus-ALZ, which has now been discontinued alongside an Open Label Extension study.

IWO : 312.71 (-0.01%)
VTI : 298.49 (-0.19%)
IWM : 241.22 (+0.25%)
SAVA : 4.06 (+6.01%)
Two Satellite Launches, New Govt Funding Propel Rocket Lab Stock: Retail Joins the Ride

If pre-market gains hold, Rocket Lab shares could set a new all-time high at the open, following Friday's record-breaking close.

RKLB : 25.36 (-0.31%)
VTI : 298.49 (-0.19%)
IWM : 241.22 (+0.25%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Fund Summary

The iShares Russell 2000 ETF seeks to track the investment results of an index composed of small-capitalization U.S. equities. The Fund seeks investment results that correspond to the performance of the Russell 2000 Index. The Index measures the performance of the small-capitalization sector of the U.S....

See More

Key Turning Points

3rd Resistance Point 243.85
2nd Resistance Point 242.73
1st Resistance Point 241.67
Last Price 241.22
1st Support Level 239.50
2nd Support Level 238.37
3rd Support Level 237.32

See More

52-Week High 244.98
Last Price 241.22
Fibonacci 61.8% 219.09
Fibonacci 50% 211.09
Fibonacci 38.2% 203.09
52-Week Low 177.20

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar